According to Theravance Biopharma 's latest financial reports the company's current earnings are C$62.01 Million. In 2023 the company made an earning of -C$68.44 Million, an increase over its 2022 earnings that were of -C$0.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.